Initiator Pharma A/S

Initiator Pharma A/S EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Initiator Pharma A/S (INIT.ST) as of Nov 3, 2026 is -18.20 M DKK. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 319,164.00 DKK — a change of -5,802.65% (lower).

EBITDA

-18.20 MDKK

YoY

-5,802.65%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Initiator Pharma A/S is 2025 -18.20 M DKK. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Initiator Pharma A/S was 2024 319,164.00 DKK. It decreases by -5,802.65% lower compared to the previous year.

The Initiator Pharma A/S EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
81,683.08 DKK
Jan 1, 2019
83,839.98 DKK
Jan 1, 2020
23,053.73 DKK
Jan 1, 2021
767,062.26 DKK
Jan 1, 2022
-27.53 M DKK
Jan 1, 2023
2.43 M DKK
Jan 1, 2024
319,164.00 DKK
Jan 1, 2025
-18.20 M DKK
The Initiator Pharma A/S EBITDA history
YEAREBITDAYoY
-18.20 MDKK-5,802.65%
319,164.00DKK-86.87%
2.43 MDKK-108.83%
-27.53 MDKK-3,689.25%
767,062.26DKK+3,227.28%
23,053.73DKK-72.50%
83,839.98DKK+2.64%
81,683.08DKK+10.84%
73,693.54DKK+707.83%
9,122.40DKK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Initiator Pharma A/S Stock analysis

What does Initiator Pharma A/S do? Initiator Pharma A/S is a clinical-stage biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. The company develops novel therapeutics targeting monoamine reuptake transporters for central nervous system disorders, with a focus on erectile dysfunction treatments. Initiator Pharma A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Initiator Pharma A/S stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Initiator Pharma A/S is -18.20 M DKK in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Initiator Pharma A/S changed from 319,164.00 DKK to -18.20 M DKK, representing a -5,802.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Initiator Pharma A/S since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s DKK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Initiator Pharma A/S historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Initiator Pharma A/S

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Initiator Pharma A/S